Prospective evaluation of a surgical solution for breast cancer-associated lymphedema
Ended Project Grant Awarded Last action
- Award ID
- R44CA203608
- Recipient
-
Fibralign Corporation UEI SKHKN4KZAE48
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,330,246
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $3,647,980.00 Federal
- $682,266.00 Non-federal
- Place of performance
- Union City, CA 94587, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $682,266 | $0 | |
| Amendment | $682,266 | $682,266 | |
| Amendment | $32,935 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $252,861 | $0 | |
| Amendment | $1,695 | $0 | |
| Amendment | $998,174 | $0 | |
| Original award | $997,783 | $0 |
Quick answers
Who received award R44CA203608?
R44CA203608 was awarded to Fibralign Corporation by National Cancer Institute (National Institutes of Health) on September 1, 2017.
How much is award R44CA203608 worth?
$4,330,246 has been obligated on R44CA203608: $3,647,980 in federal funding and $682,266 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award